Doximity (NYSE:DOCS): A Quality Investment with Superior Returns on Capital
Doximity (DOCS) excels as a quality stock: 125% ROIC, no debt, strong cash conversion. See why its fundamentals appeal to long-term investors.
ChartMill2 days agoDOCS
3 Reasons to Avoid DOCS and 1 Stock to Buy Instead
Since March 2026, Doximity has been in a holding pattern, posting a small return of 2.8% while floating around $26.41. The stock also fell short of the S&P 500’s 12.1% gain during that period.
Yahoo2 days agoDOCS
Amplitude, GitLab, Doximity, Freshworks, and Sprinklr Shares Skyrocket, What You Need To Know
A number of stocks jumped in the afternoon session after quarterly earnings and upbeat corporate commentary signaled that artificial intelligence is driving growth across enterprise software rather than threatening legacy business models.
Yahoo7 days agoDOCS
Doximity (DOCS) Price Target Increased by 12.72% to 30.32
Fintel7 days agoDOCS
1 Software Stock on Our Buy List and 2 Facing Challenges
Software is eating the world, and virtually no business is left untouched by it. Companies bringing it to life have been rewarded with explosive earnings growth, and the upward trend shows no signs of stopping as the industry has posted a 44.6% gain over the past six months, beating the S&P 500 by 32.9 percentage points.
Yahoo7 days agoDOCS
Overworked Doctors Bet on AI to Boost Their Pay
SAN FRANCISCO, August 25, 2026--Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced new data indicating that physicians are finding an unexpected source of optimism in AI. Rather than viewing the technology as a threat, nearly a quarter expect it to increase their total compensation within the next year, and two-thirds believe staying current with AI will give them a meaningful earnings edge over peers who don't.
Yahoo10 days agoDOCS
Reasons to Retain Doximity Stock in Your Portfolio for Now
DOCS' AI expansion is opening new growth avenues, but rising AI costs and tight pharma budgets could temper near-term gains.
Yahoo10 days agoDOCS
Barclays Maintains Equal-Weight on Doximity, Raises Price Target to $27
Barclays analyst Glen Santangelo maintains Doximity (NYSE:DOCS) with a Equal-Weight and raises the price target from $20 to $27.
Benzinga14 days agoDOCS
Doximity (DOCS) Stock Looks Cheap On Cash Flow Yet Fair On Earnings
Doximity stock has had a difficult five year stretch, with shareholders seeing the share price decline 71.8%, even as recent AI driven products have drawn fresh attention. At the current price near US$24.94, the key issue is whether the latest enthusiasm lines up with what the intrinsic value and market based checks say about Doximity. Over five years, the share price decline of 71.8% points to investors reassessing what they are willing to pay for Doximity. Growth expectations around...
Yahoo15 days agoDOCS
Doximity (DOCS) Could Be 26% Below Fair Value On Strong Earnings Guidance
Doximity (DOCS) is back in focus after its latest quarterly report showed higher sales, raised full year revenue guidance, and continued margin pressure tied to heavier spending on AI tools. See our latest analysis for Doximity. At a share price of US$24.94, Doximity has seen a 30 day share price return of 15.89% and a 90 day share price return of 25.58%. However, the year to date share price return is down 42.39% and the 1 year total shareholder return is down 60.79%. This points to...
Yahoo16 days agoDOCS
A Doximity Director Moved 7,500 Shares the Day the Stock Popped 33%. Here's What to Know
This sale was executed under a pre-established Rule 10b5-1 trading plan adopted in February.
Yahoo17 days agoDOCS
What Investors Should Know of This Doximity Officer's Latest Insider Transaction
Sitaram's sale was driven by tax obligations from option exercises and RSU vesting, not a shift in conviction.
Yahoo17 days agoDOCS
Doximity Handed Its President 150,000 Options Last Month. Here's What the Latest Filing Signals for Investors
Restricted stock unit vesting triggered a routine sell-to-cover sale, reducing Zatz's direct holdings by 8% while leaving him with $1.3 million in remaining equity.
Yahoo17 days agoDOCS
Doximity's New CFO Just Filed His First Form 4. Here's What Long-Term Investors Should Know.
This non-discretionary sale tied to restricted stock unit vesting reduced the CFO's direct holdings by 3%, though he retains a $12.1 million equity stake in the healthcare platform operator.
Yahoo17 days agoDOCS
Doximity's Co-Founder Just Filed a Form 4. Is There Anything in It Worth Worrying About?
Tangney executed a non-discretionary sale to cover tax withholding on vesting equity awards.
Yahoo17 days agoDOCS
Rapid7, 8x8, Doximity, Marqeta, and Tenable Shares Are Soaring, What You Need To Know
A number of stocks jumped in the afternoon session after the Bureau of Labor Statistics reported that the July Producer Price Index was completely flat month-over-month—coming in below expectations for a 0.2% increase—following the Consumer Price Index print (released earlier in the week) which showed a mild 0.1% monthly increase and an annual inflation rate cooling to 3.4%. Together, the data points suggest price pressures are moderating across both wholesale and consumer levels, taking the urg
Yahoo19 days agoDOCS
Doximity (DOCS) Q1 2027 Earnings Call Transcript
Revenue grew 7% as AI adoption accelerated, with AI Scribe users surging 10-fold in July.
Yahoo21 days agoDOCS
Doximity Doubled, Then Gave Most of It Back. Here’s Why the Market Doesn’t Trust the Rally
For a few hours on August 7, Doximity, Inc. (NYSE:DOCS) appeared to be the story of the earnings season. The medical-networking platform’s stock more than doubled overnight following its fiscal first-quarter report, with CEO Jeffrey Tangney mentioning a metric that piqued traders’ interest: the company’s new AI Search product, he claimed on the results call, […]
Yahoo21 days agoDOCS
Truist Securities Maintains Hold on Doximity, Raises Price Target to $24
Truist Securities analyst Jailendra Singh maintains Doximity (NYSE:DOCS) with a Hold and raises the price target from $19 to $24.
Benzinga22 days agoDOCS
1 Cash-Producing Stock with Promising Prospects and 2 We Ignore
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.
Yahoo23 days agoDOCS
Atlassian and Doximity Just Surged 30% After Earnings: 3 Software Stocks with the Same Setup
GitLab, UiPath, and Asana have similar setups that could lead to big post-earnings jumps.
Yahoo24 days agoDOCS
Wells Fargo Downgrades Doximity (DOCS)
Fintel24 days agoDOCS